Natural OTCs Sprout From Firms’ Innovations Within Monograph Limits
This article was originally published in The Tan Sheet
Executive Summary
Recently launched OTCs from Earth’s Care and LaCorium Health target consumers who want natural products with the safety and efficacy assured under FDA’s drug monographs. Supplement and homeopathic product makers also target consumers with natural alternatives to traditional pharmaceuticals.
You may also be interested in...
Adverse Events Spark FDA Evaluation Of Topical Acne Ingredients
A recent uptick in the number of adverse events reported for benzoyl peroxide and salicylic acid products has pushed the regulatory agency to take a closer look at the potential for safety issues.
J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.
Ensuring Leading Position For GSK Consumer Products Touted In Management Shift
GlaxoSmithKline restructures its management to ensure adequate focus on its three core areas, pharmaceutical, vaccine and consumer. Consumer product sales fell 3% to $1.72 billion in the third quarter due to continuing supply interruptions and generally weaker markets.